RxDoctor Payments DataLook up a doctor →

Brian Michael, MD

Endocrinology, Diabetes & Metabolism · Gettysburg, PANPI 1942237722

Payments from drug & device makers

$63,046in general payments, 2019–2025

Across 903 payments — averaging $69.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$45K
  • Corcept Therapeutics$3K
  • Novo Nordisk$3K
  • AbbVie$2K
  • Lilly USA, LLC$1K
  • Tandem Diabetes Care, Inc.$996
  • plus $8K from 47 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Amgen(2 entities)163$44,683
Corcept Therapeutics22$3,262
Novo Nordisk169$2,574
AbbVie54$2,218
Lilly USA, LLC93$1,490
Tandem Diabetes Care, Inc.12$996
Sanofi-aventis U.S. LLC51$843
Cequr Corporation7$661
Dexcom, Inc.32$566
Mannkind Corporation27$498
Xeris Pharmaceuticals, Inc.24$465
Bayer25$453
Boehringer Ingelheim26$388
AstraZeneca(2 entities)21$354
Amneal Pharmaceuticals LLC13$262
Esperion Therapeutics, Inc.12$259
Antares Pharma, Inc.14$253
Radius Health, Inc.8$230
Sandoz10$229
IBSA Pharma Inc.10$225
Pfizer10$198
OPKO Pharmaceuticals, LLC12$176
Recordati_rare_diseases_inc.10$166
Insulet Corporation9$148
Valeritas, Inc.1$139
Ascendis Pharma Endocrinology Inc4$113
Zealand Pharma US, Inc.5$89
Medtronic(2 entities)5$80
Amarin Pharma, Inc.5$78
Kyowa Kirin, Inc.3$72
BETA Bionics, Inc.4$70
Eton Pharmaceuticals, Inc.1$70
Eisai Inc.3$64
Novartis4$55
Ultragenyx Pharmaceutical Inc.3$54
Abbott3$54
Ipsen Biopharmaceuticals, Inc3$51
Sequel Med Tech, LLC2$48
Johnson & Johnson3$48
Tolmar, Inc.2$48
Nestle Healthcare Nutrition Inc.3$44
Takeda Pharmaceuticals U.S.A., Inc.2$36
Halozyme Inc2$33
Bigfoot Biomedical Inc1$31
Amryt Pharma Holdings Ltd2$31
Azurity Pharmaceuticals, Inc.1$22
Clarus Therapeutics Inc.1$20
Acella Pharmaceuticals, LLC1$18
Rhythm Pharmaceuticals, Inc.1$18
EUSA Pharma (US) LLC1$17
Madrigal Pharmaceuticals1$17
Merck1$14
Tempus AI, Inc1$14

How this compares

$63,046 in reported general payments places this provider in the 85th percentile of 388 endocrinology, diabetes & metabolism providers in Pennsylvania.

See all endocrinology, diabetes & metabolism providers in Pennsylvania →

Medicare billing

Part B allowed, 2024
$174,025
Medicare patients
444
Services billed
1,549

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Gettysburg

See the full list for Pennsylvania →

Where these figures come from

Is this you, or does something look wrong? →